Changyuan Ren
Beijing, 100070, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
MET-associated immune prognostic signature predicts survival and guides personalized therapy in glioma.
Journal: Acta neuropathologica communications
Published: May 11, 2026
Dissection of spatial hypoxic and inflammatory ecosystem in glioblastoma.
Journal: Cancer letters
Published: April 01, 2026
Single-cell multi-omics dissection of RevitalAge Markers uncovers age-dependent immunotherapy resistance and druggable targets in melanoma.
Journal: Biology direct
Published: January 28, 2026
Epithelial-Mesenchymal Transition Related Score Functions as a Predictive Tool for Immunotherapy and Candidate Drugs in Glioma.
Journal: Journal of chemical information and modeling
Published: August 08, 2024
A novel chemokine-based signature for prediction of prognosis and therapeutic response in glioma.
Journal: CNS neuroscience & therapeutics
Published: May 12, 2022
LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma.
Journal: CNS neuroscience & therapeutics
Published: October 25, 2021
Comprehensive transcriptomic characterization reveals core genes and module associated with immunological changes via 1619 samples of brain glioma.
Journal: Cell death & disease
Published: May 20, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026